These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11577579)

  • 21. Kidney function after islet transplant alone in type 1 diabetes: impact of immunosuppressive therapy on progression of diabetic nephropathy.
    Maffi P; Bertuzzi F; De Taddeo F; Magistretti P; Nano R; Fiorina P; Caumo A; Pozzi P; Socci C; Venturini M; del Maschio A; Secchi A
    Diabetes Care; 2007 May; 30(5):1150-5. PubMed ID: 17259471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
    Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
    Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes.
    Bellin MD; Kandaswamy R; Parkey J; Zhang HJ; Liu B; Ihm SH; Ansite JD; Witson J; Bansal-Pakala P; Balamurugan AN; Papas KK; Sutherland DE; Moran A; Hering BJ
    Am J Transplant; 2008 Nov; 8(11):2463-70. PubMed ID: 18808408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of various immunosuppressive monotherapies on survival and histopathology of monkey islet xenografts in rats.
    Balamurugan AN; Nelson EJ; Ramakrishna B; Gunasekaran S
    Xenotransplantation; 2007 Jul; 14(4):316-22. PubMed ID: 17669173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of a sirolimus/tacrolimus-based immunosuppressive regimen on kidney function after islet transplantation.
    Andres A; Toso C; Morel P; Demuylder-Mischler S; Bosco D; Baertschiger R; Pernin N; Bucher P; Majno PE; Bühler LH; Berney T
    Transplant Proc; 2005 Mar; 37(2):1326-7. PubMed ID: 15848711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful simultaneous islet-kidney transplantation using a steroid-free immunosuppression: two-year follow-up.
    Lehmann R; Weber M; Berthold P; Züllig R; Pfammatter T; Moritz W; Mädler K; Donath M; Ambühl P; Demartines N; Clavien And PA; Andreia Spinas G
    Am J Transplant; 2004 Jul; 4(7):1117-23. PubMed ID: 15196070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin independence in type I diabetes after transplantation of unpurified islets from single donor with 15-deoxyspergualin.
    Gores PF; Najarian JS; Stephanian E; Lloveras JJ; Kelley SL; Sutherland DE
    Lancet; 1993 Jan; 341(8836):19-21. PubMed ID: 8093268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current status of immunosuppressive agents for solid organ transplantation in children.
    Coelho T; Tredger M; Dhawan A
    Pediatr Transplant; 2012 Mar; 16(2):106-22. PubMed ID: 22360399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunosuppression for pancreatic islet transplantation.
    Berney T; Buhler LH; Majno P; Mentha G; Morel P
    Transplant Proc; 2004 Mar; 36(2 Suppl):362S-366S. PubMed ID: 15041369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Interleukin-2 receptor blockers in renal transplantation].
    Basić-Jukić N; Bubić-Filipi L; Danić A; Pasini J; Kes P
    Acta Med Croatica; 2004; 58(5):395-9. PubMed ID: 15756806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term graft function after allogeneic islet transplantation.
    Lakey JR; Kin T; Warnock GL; Shapiro AM; Tsapogas P; Imes S; Korbutt GS; Kneteman NM; Rajotte RV; Ryan EA
    Cell Transplant; 2007; 16(4):441-6. PubMed ID: 17658134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perioperative immunosuppression as a critical determinant of early outcome after discordant xenoislet transplantation: a comparative study.
    Troppmann C; Papalois BE; Gruessner AC; Moon C; Matas AJ; Sehgal SN; Nakhleh RE; Gruessner RW
    Transplant Proc; 1996 Apr; 28(2):981-3. PubMed ID: 8623487
    [No Abstract]   [Full Text] [Related]  

  • 33. T-cell-specific immunosuppression results in more than 53 days survival of porcine islets of langerhans in the monkey.
    Rijkelijkhuizen JK; Haanstra KG; Wubben J; Töns A; Roos A; van Gijlswijk-Janssen DJ; Ringers J; Bouwman E; Jonker M
    Transplantation; 2003 Nov; 76(9):1359-68. PubMed ID: 14627916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sirolimus and islet transplants.
    Hering BJ; Wijkstrom M
    Transplant Proc; 2003 May; 35(3 Suppl):187S-190S. PubMed ID: 12742495
    [No Abstract]   [Full Text] [Related]  

  • 35. [Islets of Langerhans grafts and pancreas transplantation].
    Lefrançois N; Martin X
    Rev Prat; 1992 May; 42(9):1090-2. PubMed ID: 1496235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunosuppressive effect in combination therapy of cyclosporine A, FK 506, and 15-deoxyspergualin on pancreatic islet xenotransplantation.
    Ueno M; Nakajima Y; Segawa M; Hisanaga M; Yabuuchi H; Yoshimura A; Nakano H
    Transplant Proc; 1992 Apr; 24(2):638-40. PubMed ID: 1373546
    [No Abstract]   [Full Text] [Related]  

  • 37. Insulin replacement therapy in patients with type 1 diabetes by isolated pancreatic islet transplantation.
    Poradzka A; Wroński J; Jasik M; Karnafel W; Fiedor P
    Acta Pol Pharm; 2013; 70(6):943-50. PubMed ID: 24383317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Islet cell and pancreas transplantation in diabetes: status 1996].
    Bretzel RG
    Ther Umsch; 1996 Dec; 53(12):889-901. PubMed ID: 9036567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcineurin inhibitor-free immunosuppressive regimen in type 1 diabetes patients receiving islet transplantation: single-group phase 1/2 trial.
    Maffi P; Berney T; Nano R; Niclauss N; Bosco D; Melzi R; Mercalli A; Magistretti P; De Cobelli F; Battaglia M; Scavini M; Demuylder-Mischler S; Secchi A; Piemonti L
    Transplantation; 2014 Dec; 98(12):1301-9. PubMed ID: 25286053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Balancing efficacy and toxicity in kidney-transplant immunosuppression.
    Leichtman AB
    N Engl J Med; 2007 Dec; 357(25):2625-7. PubMed ID: 18094383
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.